This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (32)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

PAUL S. PORTER, MD; JOHN S. LYLE, MD

Arch Dermatol. 1966;93(4):402-403.

Abstract
Oral contraceptive therapy should be added to the list of those predisposing factors known to enhance yeast growth in the vagina.

Thirteen patients with yeast vulvovaginitis due to oral contraceptive therapy were seen during a six-month period. The potassium hydroxide (KOH) preparation confirmed the diagnosis in 11 of these patients; in selected patients, cultures were necessary. The germ-tube method of identification was rapid and efficient.

Accepted methods for treatment of yeast vulvovaginitis may be only temporarily effective unless the oral contraceptive is discontinued.

Author Affiliations
HANOVER, NH

From the Department of Dermatology (Dr. Porter) and the Department of Obstetrics and Gynecology (Dr. Lyle) Hitchcock Clinic, Hanover, NH and the Department of Obstetrics and Gynecology, Dartmouth Medical School.

Footnotes
Accepted for publication Jan 19, 1966.

Reprint requests to the Department of Dermatology, Hitchcock Clinic, Hanover, NH 03755 (Dr. Porter).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Experience in Monitoring Drug Reactions in Outpatients: The Kaiser-Permanente Drug Monitoring System
Friedman et al.
JAMA 1971;217:567-572.
ABSTRACT  

Cutaneous Side Effects of Oral Contraceptives
Jelinek
Arch Dermatol 1970;101:181-186.
ABSTRACT  

Ecology of Candida Albicans in Candidiasis of the Groin
Lynch et al.
Arch Dermatol 1969;99:154-160.
ABSTRACT